AbbVie (ABBV.US) has reached an acquisition agreement to expand its presence in the field of autoimmune diseases.

AbbVie (ABBV.US) announced that it has reached a final agreement with Nimble Therapeutics.

Zhitong FinanceDec 16 21:07

AbbVie Announces Leadership Change With New Appointment

TipRanksDec 14 05:29

AbbVie: David R. Purdue Will Be Senior Vice President, Controller

Dow JonesDec 14 05:10

AbbVie: Kevin K. Buckbee, Senior Vice President, Controller, Plans to Retire From Controller Role Effective March 1

Dow JonesDec 14 05:09

This Drugmaker's (ABBV) Parkinson's Medication Just Cleared A Key Hurdle – Is It Primed For A Monster Year In 2025?

Yahoo FinanceDec 14 03:00

AbbVie to Buy Nimble Therapeutics

MT NewswiresDec 13 22:43